# The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD

> **NCT00539786** · NA · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Proton pump inhibitor (rabeprazole)

## Key facts

- **NCT ID:** NCT00539786
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-03
- **Primary completion:** 2011-04
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00539786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00539786, "The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00539786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*